CASIA OpenIR

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
A novel estrogen receptor α-targeted near-infrared fluorescent probe for in vivo detection of breast tumor 期刊论文
Molecular Pharmaceutics, 2018, 卷号: 15, 期号: 10, 页码: 4702-4709
Authors:  Tang Chu;  Du Yang;  Liang Qian;  Cheng Zhen;  Tian Jie
View  |  Adobe PDF(1175Kb)  |  Favorite  |  View/Download:27/9  |  Submit date:2019/02/18
Breast Cancer, Nir Fluorescent Probe, Era-targeted ImagIng, In Vivo Detection  
Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy 期刊论文
Molecular Pharmaceutics, 2017, 卷号: 14, 期号: 11, 页码: 3978-3986
Authors:  Du Yang;  Liang Xiaolong;  Li Yuan;  Sun Ting;  Jin Zhengyu;  Xue Huadan;  Tian Jie
View  |  Adobe PDF(4708Kb)  |  Favorite  |  View/Download:16/3  |  Submit date:2019/02/18
Programmed Cell Death-1 (Pd-1), Near-infrared Fluorescence (Nirf) Imaging, Pet Imaging, Doxorubicin (Dox), Breast Cancer, Therapy  
Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy 期刊论文
MOLECULAR PHARMACEUTICS, 2017, 卷号: 14, 期号: 11, 页码: 3978-3986
Authors:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Jin, Zhengyu;  Xue, Huadan;  Tian, Jie
View  |  Adobe PDF(4708Kb)  |  Favorite  |  View/Download:92/29  |  Submit date:2018/01/03
Programmed Cell Death-i (Pd-i)  Near-infrared Fluorescence (Nirf) Imaging Pet Imaging  Doxorubicin (Dox)  Breast Cancer  Therapy  
From PET/CT to PET/MRI: Advances in Instrumentation and Clinical Applications 期刊论文
MOLECULAR PHARMACEUTICS, 2014, 卷号: 11, 期号: 11, 页码: 3798-3809
Authors:  Hu, Zhenhua;  Yang, Weidong;  Liu, Haixiao;  Wang, Kun;  Bao, Chengpeng;  Song, Tianming;  Wang, Jing;  Tian, Jie
View  |  Adobe PDF(551Kb)  |  Favorite  |  View/Download:101/14  |  Submit date:2015/08/12
Positron Emission Tomography/computed Tomography (Pet/ct)  Positron Emission Tomography/magnetic Resonance Imaging (Pet/mri)  Time-of-flight (Tof)  Silicon Photomultiplier (Sipm)  Attenuation Correction  Oncology  Neurologic Disease  Cardiology  
Two Y-90-Labeled Multimeric RGD Peptides RGD4 and 3PRGD2 for Integrin Targeted Radionuclide Therapy 期刊论文
MOLECULAR PHARMACEUTICS, 2011, 卷号: 8, 期号: 2, 页码: 591-599
Authors:  Liu, Zhaofei;  Shi, Jiyun;  Jia, Bing;  Yu, Zilin;  Liu, Yan;  Zhao, Huiyun;  Li, Fang;  Tian, Jie;  Chen, Xiaoyuan;  Liu, Shuang;  Wang, Fan
Adobe PDF(4632Kb)  |  Favorite  |  View/Download:62/4  |  Submit date:2015/11/08
Integrin Alpha(v)Beta(3)  Arg-gly-asp (Rgd)  Y-90  Tumor  Radionuclide Therapy  
Two (90)Y-Labeled Multimeric RGD Peptides RGD4 and 3PRGD2 for Integrin Targeted Radionuclide Therapy 期刊论文
MOLECULAR PHARMACEUTICS, 2011, 卷号: 8, 期号: 2, 页码: 591-599
Authors:  Liu, ZF;  Shi, JY;  Jia, B;  Yu, ZL;  Liu, Y;  Zhao, HY;  Li, F;  Tian, J;  Chen, XY;  Liu, SA;  Wang, F;  Wang, Fan
Adobe PDF(4632Kb)  |  Favorite  |  View/Download:54/8  |  Submit date:2015/08/12
Radionuclide Therapy  90y  Integrin Rvβ3  Arg-gly-asp (Rgd)